Skip to Content

  • Search

View Additional Section Content

ECOG E3612 - A Randomized Phase II Trial of Ipilimumab with or Without Bevacizumab in Patients with Unresectable Stage III or Stage IV Melanoma

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/record/NCT01950390?term=NCT01950390&rank=1

Clinical Trial Categories

  • Melanoma
Contact
The Rosenfeld Cancer Center at 215-481-2402

Location

  • The Rosenfeld Cancer Center

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a
Test

215-481-EXAM

Clinical Trials Details